Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
In the last decade, the emergence of several, novel tickborne viruses have caused significant disease in humans. Of interest are the tickborne banyangviruses: Severe fever with thrombocytopenia syndrome virus (SFTSV), Heartland virus (HRTV), and Guertu virus (GTV). SFTSV and HRTV infection in humans...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/7/4/125 |
id |
doaj-4de3680823044500a501165bfa2dadb2 |
---|---|
record_format |
Article |
spelling |
doaj-4de3680823044500a501165bfa2dadb22020-11-24T20:53:06ZengMDPI AGVaccines2076-393X2019-09-017412510.3390/vaccines7040125vaccines7040125Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne BanyangvirusesCrystal A. Mendoza0Hideki Ebihara1Satoko Yamaoka2Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USADepartment of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USADepartment of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USAIn the last decade, the emergence of several, novel tickborne viruses have caused significant disease in humans. Of interest are the tickborne banyangviruses: Severe fever with thrombocytopenia syndrome virus (SFTSV), Heartland virus (HRTV), and Guertu virus (GTV). SFTSV and HRTV infection in humans cause viral hemorrhagic fever-like disease leading to mortality rates ranging from 6−30% of the cases. The systemic inflammatory response syndrome (SIRS) associated with SFTSV infection is hypothesized to contribute significantly to pathology seen in patients. Despite the severe disease caused by HRTV and SFTSV, there are no approved therapeutics or vaccines. Investigation of the immune response during and following infection is critical to the generation of fully protective vaccines and/or supportive treatments, and overall understanding of viral immune evasion mechanisms may aid in the development of a new class of therapeutics.https://www.mdpi.com/2076-393X/7/4/125heartlandHRTVsevere fever with thrombocytopenia syndrome virusSFTSVSFTSBanyangvirusGuertu virusinterferon antagonism |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Crystal A. Mendoza Hideki Ebihara Satoko Yamaoka |
spellingShingle |
Crystal A. Mendoza Hideki Ebihara Satoko Yamaoka Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses Vaccines heartland HRTV severe fever with thrombocytopenia syndrome virus SFTSV SFTS Banyangvirus Guertu virus interferon antagonism |
author_facet |
Crystal A. Mendoza Hideki Ebihara Satoko Yamaoka |
author_sort |
Crystal A. Mendoza |
title |
Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses |
title_short |
Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses |
title_full |
Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses |
title_fullStr |
Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses |
title_full_unstemmed |
Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses |
title_sort |
immune modulation and immune-mediated pathogenesis of emerging tickborne banyangviruses |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2019-09-01 |
description |
In the last decade, the emergence of several, novel tickborne viruses have caused significant disease in humans. Of interest are the tickborne banyangviruses: Severe fever with thrombocytopenia syndrome virus (SFTSV), Heartland virus (HRTV), and Guertu virus (GTV). SFTSV and HRTV infection in humans cause viral hemorrhagic fever-like disease leading to mortality rates ranging from 6−30% of the cases. The systemic inflammatory response syndrome (SIRS) associated with SFTSV infection is hypothesized to contribute significantly to pathology seen in patients. Despite the severe disease caused by HRTV and SFTSV, there are no approved therapeutics or vaccines. Investigation of the immune response during and following infection is critical to the generation of fully protective vaccines and/or supportive treatments, and overall understanding of viral immune evasion mechanisms may aid in the development of a new class of therapeutics. |
topic |
heartland HRTV severe fever with thrombocytopenia syndrome virus SFTSV SFTS Banyangvirus Guertu virus interferon antagonism |
url |
https://www.mdpi.com/2076-393X/7/4/125 |
work_keys_str_mv |
AT crystalamendoza immunemodulationandimmunemediatedpathogenesisofemergingtickbornebanyangviruses AT hidekiebihara immunemodulationandimmunemediatedpathogenesisofemergingtickbornebanyangviruses AT satokoyamaoka immunemodulationandimmunemediatedpathogenesisofemergingtickbornebanyangviruses |
_version_ |
1716798030864187392 |